购物车
- 全部删除
- 您的购物车当前为空
Anti-DR4/TRAIL R1 Antibody (6F81) 是一种 Mouse 抗体,靶向 DR4/TRAIL R1。Anti-DR4/TRAIL R1 Antibody (6F81) 可用于 ELISA(Cap),FCM。
Anti-DR4/TRAIL R1 Antibody (6F81) 是一种 Mouse 抗体,靶向 DR4/TRAIL R1。Anti-DR4/TRAIL R1 Antibody (6F81) 可用于 ELISA(Cap),FCM。
产品描述 | Anti-DR4/TRAIL R1 Antibody (6F81) is a Mouse antibody targeting DR4/TRAIL R1. Anti-DR4/TRAIL R1 Antibody (6F81) can be used in ELISA(Cap),FCM. |
Ig Type | Monoclonal Mouse IgG1 |
克隆号 | 6F81 |
交叉反应 | Human |
验证活性 | Flow cytometric analysis of Human TNFRSF10A(CD261) expression on HeLa cells. Cells were stained with purified anti-Human TNFRSF10A(CD261), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. |
应用 | ELISA(Cap),FCM |
推荐剂量 | FCM: 1:25-1:100; ELISA(Cap): 1:250-1:2000 |
抗体种类 | Monoclonal |
宿主来源 | Mouse |
构建方式 | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human TRAIL R1 / CD261 / TNFRSF10A (rh TRAIL R1 / CD261 / TNFRSF10A; TMPY-01720; NP_003835.2; Met1-Asn239). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | Tumor necrosis factor receptor superfamily, member 10a (TRAIL R1), also known as TRAIL receptor 1 (TRAIL R1) or CD261 antigen, is a member of the TNF-receptor superfamily. This receptor is activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL), and thus transduces cell death signal and induces cell apoptosis. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein. TRAIL R1/CD261/TNFRSF10A serves as a receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. TRAIL R1 can promote the activation of NF-kappa-B. TRAIL R1/CD261/TNFRSF10A induces apoptosis of many transformed cell lines but not of normal tissues, even though its death domain-containing receptor, DR4, is expressed on both cell types.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
偶联 | Unconjugated |
其他可选修饰符 | FITC/PE |
可提供抗体种类 | 3 |
免疫原 | Recombinant Human TRAIL R1 / CD261 / TNFRSF10A Protein (TMPY-01720) |
抗原种属 | Human |
研究领域 | Cancer Drug Targets |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容